Clinical Trials Browser

Phase 1/2 × Unknown × Noonan Syndrome × Clear all

NCT05715398 2023-02-10

BR790 in Combination With Anlotinib in Adult Subjects With Advanced Non-Small Cell Lung Cancer

Phase 1/2 Unknown

Carcinoma, Non-Small-Cell Lung, Noonan Syndrome